Zusammenfassung
Patienten mit Typ-1-Diabetes leiden an einem absoluten Insulinmangel. Ihre Prognose war bis zur Einführung von Insulin als Therapeutikum infaust, die Lebenserwartung kurz. Langzeitkomplikationen des Typ-1-Diabetes waren deshalb unbekannt. Dieses Bild hat sich inzwischen dramatisch gewandelt.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bott U, Jörgens V, Grüsser M et al (1994) Predictors of glycaemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme. Diabetic Medicine 11:362–371
Bott S, Bott U, Berger M, Mühlhauser I (1997) Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 40:926–932
Cranston I, Lomas J, Maran A et al (1994): Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 344(8918): 283–287
Dreyer M, Berger M, Kiess W et al (2003) Therapie des Diabetes mellitus Typ 1. In: Scherbaum WA, Landgraf R (Hrsg) Evidenzbasierte Diabetes-Leitlinie DDG. Diabetes und Stoffwechsel 12:Suppl 2,49–66
Early Treatment Diabetic Retinopathy Study Research Group (1991) Fundus photographic risk factors for progression of diabetic retinopathy. Ophthalmology 98(Suppl 5): 823–833
EDIC Research Group (1998) Progression of retinopathy in the DCCT cohort after 4 yrs. Follow up in the epidemiology of diabetes interventions and complications (EDIC) study. Diabetologia 41(Suppl 1):A281
EDIC Research Group (1999) Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term followup of the Diabetes Control and Complications Trial cohort. Diabetes Care 11:99–111
Feldt-Rasmussen B, Mathiesen ER, Deckert T (1986) Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 2:1300–1304
Hanssen KF, Dahl-Jørgensen K, Lauritzen T et al (1986) Diabetic control and microvascular complications: the near-normoglycaemic experience. Diabetologia 29:677–684
Martin S, Kolb H (1998) Pathogenese und Immuntherapie des Diabetes mellitus Typ 1. Diabetes und Stoffwechsel 7:17–24
Reichard P, Nilsson BY, Rosenqvist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304–309
Schiel R, Müller UA, Ulbrich S (1997) Long-term efficacy of a 5-day structured teaching and treatment programme for intensified conventional insulin therapy and risk for severe hypoglycemia. Diabetes Research & Clinical Practice 35: 41–48
Skyler JS (2001) Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomized proof-of-concept study. Lancet 357:324–325
The Diabetes Control and Complication Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986
The Diabetes Control and Complication Trial Research Group (1995) Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 102:647–661
The Diabetes Control and Complication Trial Research Group (1995) Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Intern 47: 1703–1720
The Diabetes Control and Complications Trial Research Group (1996) The absence of a glycemie threshold for the development of long-term complications: the perspective of the Diabetes control and complications Trial. Diabetes 45: 1289–1298
The Diabetes Control and Complication Trial Research Group (1998) The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia 41: 416–423
Wang PH, Lau J, Chalmers TC (1993) Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 341(8856): 1306–1309
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Scherbaum, W.A., Gries, F.A. (2004). Typ-1-Diabetes. In: Waldhäusl, W.K., Gries, F.A., Scherbaum, W.A. (eds) Diabetes in der Praxis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18571-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-18571-7_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62166-6
Online ISBN: 978-3-642-18571-7
eBook Packages: Springer Book Archive